BUY LH · April McClain Delaney
Labcorp Holdings Inc. Common Stock (LH)
Looks like ordinary portfolio activity
| Inside their committee's jurisdiction |
|
0/32 |
| Isolated decision, not a bulk rebalance |
|
20/22 |
|
Small, thinly-followed company
Nobody needs inside information to buy a mega-cap.
|
|
5/10 |
|
A name they had never held before
A first purchase is a decision; the ninth purchase of the same holding is a standing order.
|
|
8/8 |
| Member's own account |
|
0/8 |
| Committee chair or ranking member |
|
0/8 |
|
Unusually large for this member
Against their own median trade, not an absolute threshold - and capped, because trades beyond 3x did worse, not better.
|
|
0/6 |
| Position size |
|
0/3 |
| Leveraged instrument (option) |
|
0/3 |
A high grade is not an allegation. Every input is public, and buying into an industry you work on daily is ordinary expertise. What the trade actually returned is deliberately excluded from this score and shown separately below.
It is also not a forecast. Measured across every settled trade, A-graded ones did not beat E-graded ones to any significant degree — the method page prints the table. This score says a trade looks like a decision rather than administration, and nothing more.
The filing it came from
filed in 43 days Towards the 45-day statutory limit.
Still held, as far as the filings show. No disclosed sale of this name from this account since the purchase. A sale inside its 45-day disclosure window would look exactly the same, so this is the absence of a filing rather than evidence of a position.
Not in the strategy. Either this purchase falls outside the member's committee jurisdiction, or the security has no usable price history to trade against.
This filing disclosed 38 transactions in total, of which 3 share this trade date (05 Feb 2025).
Few other trades share this date, so this reads as a discrete decision rather than a portfolio sweep.
Filed 20 Mar 2025 · source PDF
Price
52-week range $244.69 – $322.42. The marker is the entry: the first market open after this filing became public.
Labcorp Holdings Inc.
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse te…
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Analyst range | $270 – $385 |
| Employees | 71,000 |
| Instrument | ST |
| Jurisdiction tags | healthcare |
Outside this member's committee jurisdiction (aerospace, agriculture, commodities, technology).
Expressing this with options
An illustration, not a recommendation: the nearest listed expiry to a twelve-month horizon, struck near the money. Chains are live — Yahoo publishes no historical chains, so this is priced today, not when the filing was made, and the move it describes may already have happened.
Loading chain…
Outcome
| Held | This trade | S&P 500 | Alpha |
|---|---|---|---|
| 1m | -7.5% | -5.9% | -1.6% |
| 3m | +11.9% | +6.6% | +5.3% |
| 6m | +18.8% | +19.4% | -0.6% |
| 12m 1yr | +13.3% | +17.3% | -4.0% |
| now 16.7 mo | +36.2% | +39.1% | -2.9% |
| 18m | — | — | — |
| 24m | — | — | — |
| 36m | — | — | — |
| 48m | — | — | — |
| 60m 5yr | — | — | — |
Measured from the first open after disclosure — the earliest anyone reading this could have acted. The highlighted now row sits at its true place in the sequence, so where it falls tells you how long the position has run. The last 5 rows are blank because those windows have not closed yet: this trade was entered 21 Mar 2025, so anything longer than that is still running.
Other congressional trades in LH
| Grade | Date | Member | Side | Amount |
|---|---|---|---|---|
| E | 27 Mar 2026 | Alan Armstrong | purchase | $1,001 - $15,000 |
| E | 11 Feb 2026 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 04 Feb 2026 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 28 Jan 2026 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 17 Nov 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 31 Oct 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 29 Oct 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 15 May 2025 | Rob Bresnahan | purchase | $1,001 - $15,000 |
| E | 08 Apr 2025 | Rob Bresnahan | sale | $1,001 - $15,000 |
| E | 31 Mar 2025 | Gilbert Cisneros | sale partial | $1,001 - $15,000 |
| E | 28 Feb 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 27 Feb 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 25 Feb 2025 | Rob Bresnahan | purchase | $1,001 - $15,000 |
| E | 17 Feb 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| E | 08 Feb 2025 | April McClain Delaney | purchase | $1,001 - $15,000 |
| D | 06 Mar 2024 | John James | sale | $1,001 - $15,000 |
| E | 10 Nov 2023 | John James | purchase | $1,001 - $15,000 |
| E | 22 Aug 2023 | Daniel S Sullivan | sale | $1,001 - $15,000 |
| E | 22 Aug 2023 | Daniel S Sullivan | sale | $1,001 - $15,000 |
| E | 16 Dec 2020 | Susie Lee | sale | $1,001 - $15,000 |
| E | 28 Apr 2020 | Susie Lee | purchase | $1,001 - $15,000 |
| D | 18 Mar 2020 | Gilbert Cisneros | sale | $1,001 - $15,000 |
| D | 26 Apr 2019 | James M Inhofe | sale | $50,001 - $100,000 |
Trade of the